Company Directory > Biotech > Fiocruz (Oswaldo Cruz Foundation)
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Fiocruz (Oswaldo Cruz Foundation) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Fiocruz is a Brazilian public research institution affiliated with the Ministry of Health, recognized as one of the most important health, science, and technology organizations in Latin America. It focuses on public health research, education, and the production of strategic health inputs, including vaccines and medicines for the Brazilian Unified Health System (SUS). The foundation operates a vast network of research institutes, laboratories, and manufacturing facilities, such as Biomanguinhos (vaccines/reagents) and Farmanguinhos (pharmaceuticals). It plays a critical role in responding to endemic diseases like Chagas disease, yellow fever, dengue, Zika, and tuberculosis, while maintaining extensive international cooperation with global health agencies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Public Health Research & Biomanufacturing
SIZE & FINANCIALS
Employees:10000+
Founded:1900
Ownership:government
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Vaccines and Essential Medicines)
Modalities:Vaccines, Small molecule, Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Biomanguinhos, Farmanguinhos, Instituto Oswaldo Cruz (IOC)
Key Partnerships:World Health Organization (WHO), Pan American Health Organization (PAHO), NIH (USA), Institut Pasteur (France)
COMPETITION
Position:Leader
LEADERSHIP
Scientific Founders:Oswaldo Cruz
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fiocruz (Oswaldo Cruz Foundation). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.